Medicine and Dentistry
Breast Cancer
100%
Odds Ratio
49%
Malignant Neoplasm
43%
Hormone Therapy
33%
Health Care Cost
31%
Clinical Trial
30%
Uterine Cancer
30%
Cross Sectional Study
29%
COVID-19
27%
Colonoscopy
27%
Colorectal Cancer Screening
26%
Medicare
24%
Aromatase Inhibitor
23%
Oncology
20%
Health Care
20%
Diseases
19%
Awareness
19%
Intestine Preparation
18%
Skin Cancer Prevention
18%
Ovarian Cancer
18%
Decision Making
18%
Cancer Risk
18%
Neoplasm
17%
Skin Cancer
17%
Metastatic Breast Cancer
15%
Public Health
13%
Prevalence
13%
Hormone Receptor
12%
Patient Compliance
12%
End of Life Care
12%
College Student
12%
Neoadjuvant Chemotherapy
12%
Genetic Screening
12%
Comorbidity
12%
Oncologist
11%
Colorectal Carcinoma
11%
Recurrent Disease
11%
Cytoreductive Surgery
11%
Sunscreen
11%
Adjuvant Chemotherapy
11%
Sun Protection
10%
Smoking
10%
Organ Donor
10%
Primary Health Care
10%
Melanoma
10%
Cancer Therapy
10%
Adenoma
9%
Occult Blood Test
9%
Hysterectomy
9%
Retrospective Cohort Study
9%
Nursing and Health Professions
Breast Cancer
91%
Odds Ratio
41%
Hormonal Therapy
34%
Cross-Sectional Study
32%
Colonoscopy
31%
Malignant Neoplasm
30%
Diseases
28%
Confidence Interval
27%
Skin Cancer
25%
Intestine Preparation
24%
Genetic Screening
24%
Aromatase Inhibitor
23%
Metastatic Breast Cancer
21%
Cancer Therapy
15%
Nutrition Policy
15%
Health Care
13%
Adolescent
13%
Adjuvant Chemotherapy
13%
Medicare
12%
Content Analysis
12%
Cancer Chemotherapy
12%
College Student
12%
Terminal Care
12%
Cohort Analysis
11%
Hormone Receptor
10%
Patient Social Context
9%
Adenoma
9%
Neoplasm
9%
Adjuvant Therapy
9%
Health Care Personnel
9%
Compliance
8%
Gastroenterologist
8%
Pandemic
8%
Patient Participation
8%
Medical Oncologist
8%
Cancer Adjuvant Therapy
7%
Recurrent Disease
7%
Cancer Prevention
7%
Prospective Cohort Study
7%
Patient Compliance
6%
Health Care Cost
6%
Practice Guideline
6%
Adverse Event
6%
Electronic Medical Record
6%
Mental Health
6%
Interrater Reliability
6%
Cyclophosphamide Plus Doxorubicin Plus Etoposide Plus Prednisolone Plus Vincristine
6%
Cancer Screening
6%
Prevention and Control
6%
Surgery
6%
Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
44%
Chemotherapy
34%
Malignant Neoplasm
29%
Diseases
22%
Aromatase Inhibitor
22%
Ovary Cancer
18%
Clinical Trial
18%
Colon Carcinoma
18%
Hormone Cancer Therapy
14%
Cross-Sectional Study
13%
Skin Cancer
12%
Coronavirinae
12%
Colorectal Carcinoma
12%
Recurrent Disease
10%
Sunscreen
10%
Cohort Study
8%
Endocrine Therapy
7%
Comorbidity
7%
SARS Coronavirus
7%
Folinic Acid
7%
Fluorouracil
7%
Hormone Receptor
7%
Endometrium Cancer
6%
Oxaliplatin
6%
Irinotecan
6%
Cyclophosphamide Plus Doxorubicin Plus Etoposide Plus Prednisolone Plus Vincristine
6%
Pandemic
6%
Prospective Cohort Study
6%
Fluoride
6%
Cancer Chemotherapy
6%
Infection
6%
Venous Thromboembolism
6%
Uterus Cancer
6%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase Inhibitor
6%
Bisphosphonic Acid Derivative
6%
Anastrozole
6%
Hematologic Malignancy
6%
Chemoradiation Therapy
6%
Multiple Myeloma
6%
Bevacizumab
6%
